Skip to main content

Patricia Randall, Patricia Schreck, Charles Cantor, Cheri Walker, Mark Gardner

Premium

Patricia Randall has become vice president, general counsel, and chief legal officer of Matritech. Prior to joining Matritech, she was vice president and general counsel of

Robotic Vision Systems

. Before that, she was vice president and general counsel of the electronic interconnect product manufacturer Hadco. Randall also previously taught at Northeastern University School of Law and at Harvard Law School. She holds a JD from Northeastern University School of Law and a BA from American University.


Patricia Schreck has become executive vice president and general counsel of Incyte. Schreck was previously chief patent counsel at Elan Drug Delivery. She has also served as general counsel for diaDexus, a joint venture between Incyte and GlaxoSmithKline. Before that she worked at GSK in patent roles. Schreck will replace Lee Bendekgey, who was general counsel as well as general manager of the information products group for Incyte.


Charles Cantor has joined the scientific advisory board of Michigan-based GeneGo. Cantor is currently chief scientific officer and a board director of Sequenom. He is also director of the Center for Advanced Biotechnology at Boston University. Cantor was previously the director of the Human Genome Center of the Department of Energy at Lawrence Berkeley Laboratory. He founded Selectx Pharmaceuticals in 2002.


Cheri Walker has been appointed vice president, corporate development and Mark Gardner has been appointed vice president of process improvement at Invitrogen.

Walker comes to Invitrogen from Deutsche Bank, where she was vice president, North American equity research.

Gardner is a Six Sigma Master Black Belt — which means that he has completed a special program on best practices in management. His prior experience includes six sigma and acquisition integration at the IT division of General Electric Medical Systems. Before joining GE, he was a consultant at McKinsey & Company and a lieutenant commander and pilot in the United States Navy.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.